Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Xeris Pharmaceuticals Inc (XERS)

Xeris Pharmaceuticals Inc (XERS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Xeris Pharmaceuticals Inc 180 N. LaSalle Street Suite 1810 Chicago IL 60601 USA

P: 844-445-5704

Description:

Xeris Pharmaceuticals, Inc. produces peptides, proteins, antibodies, molecules, auto-injectors, multi-dose pens and infusion pumps to treat endocrine and metabolic diseases. The company's proprietary formulation technologies consist of XeriSol (TM) and XeriJect(TM). Xeris Pharmaceuticals, Inc. is based in Chicago, United States.

Key Statistics

Overview:

Market Capitalization, $K 229,120
Shares Outstanding, K 26,987
Annual Sales, $ 2,470 K
Annual Net Income, $ -60,080 K
Last Quarter Sales, $ 320 K
Last Quarter Net Income, $ -34,390 K
60-Month Beta -0.44
% of Insider Shareholders 7.43%
% of Institutional Shareholders 62.44%
Float, K 24,982
% Float 92.57%

Growth:

1-Year Return -56.93%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 11/06/19
Earnings Per Share ttm -4.04
EPS Growth vs. Prev Qtr -19.63%
EPS Growth vs. Prev Year 58.31%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00

XERS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -2.15
Price/Earnings to Growth N/A
Return-on-Equity (After Tax) -107.65
Return-on-Assets (Before Tax) -68.67
Profit Margin % -2,432.39
Net Margin % N/A
Debt/Equity 0.39
Price/Sales 88.02
Price/Cash Flow N/A
Price/Book 2.77
Book Value/Share 2.78
Interest Coverage -22.56
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar